women with newly diagnosed triple negative breast cancer with an indication for (neo-)adjuvant ATC-based chemotherapy and of intent to start anticancer treatment;
age between 18 and 75 years;
written informed consent;
body mass index ≥ 19.
You may not be if
Allergic to any of the ingredients of the diet;
Known history of cardiac dysfunction;
Severe morbidity with the inability to receive anticancer treatment.
Participation in another clinical trial with an intervention arm (database and/or biobank studies excluded);
Pregnant women
Previous treatment with anthracycline
Estrogen receptor positive status
Clareo Health | Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
